SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554757-12-000408
Filing Date
2012-11-19
Accepted
2012-11-19 15:43:26
Documents
9
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 tapimmune10q.htm 10-Q 713750
2 ex_31-1.htm EX-31.1 15549
3 ex_32-1.htm EX-32.1 5857
  Complete submission text file 0001554757-12-000408.txt   2687423

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE tpiv-20120930.xml EX-101.INS 329721
5 XBRL SCHEMA FILE tpiv-20120930.xsd EX-101.SCH 30867
6 XBRL CALCULATION FILE tpiv-20120930_cal.xml EX-101.CAL 25049
7 XBRL DEFINITION FILE tpiv-20120930_def.xml EX-101.DEF 14162
8 XBRL LABEL FILE tpiv-20120930_lab.xml EX-101.LAB 122469
9 XBRL PRESENTATION FILE tpiv-20120930_pre.xml EX-101.PRE 92758
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 121214527
SIC: 2834 Pharmaceutical Preparations